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Sir, The response by Lange et al. (2014) provides important con-
firmatory information. The coincidence of the FN 119 domain mu-
tation (p.P30091L) with the kinase domain variant (p.R32450W or
R279W) in all patients previously reported by Lange et al. (2005)
confirms speculation (Hedberg et al., 2013; Pfeffer et al., 2013)
that the HMERF in the original family was primarily a result of the
p.P30091L FN 119 mutation, and not to the kinase domain variant
(p.R32450W or R279W). The kinase domain variant (p.R32450W
or R279W) was originally reported to be the cause of HMERF by
Lange et al. (2005), but has subsequently been reported in healthy
control subjects. On the other hand, the p.P30091L FN 119 mu-
tation has been reported repeatedly and exclusively in HMERF
families.
Lange et al. (2014) suggest that we contradict ourselves re-
garding the pathogenicity of the p.P30091L variant, citing out
of context (and out of chronological order) our report in which
we considered p.P30091L as a possible neutral variant (Pfeffer
et al., 2014). However, we had also written that the variant
may be pathogenic with variable penetrance and/or expressivity.
At that time, it was the first published report of HMERF with this
mutation, so we could not reach a final conclusion with confi-
dence. Since then, another study confirmed the association of
the p.P30091L mutation with HMERF (Palmio et al., 2013), and
in retrospect, a patient with this mutation and ‘myopathy with
cytoplasmic aggregates’ (Vasli et al., 2012) could also have
HMERF. Lange et al. (2014) now report that their HMERF patients
originally reported in 2005 have this same mutation. Although we
had previously been uncertain regarding the pathogenicity of the
p.P30091L variant, current evidence repeatedly links this mutation
with HMERF (Vasli et al., 2012; Hedberg et al., 2013; Palmio
et al., 2013; Pfeffer et al., 2014; Lange et al., 2014).
The very interesting question is the reason for the more severe
disease expressivity and complete penetrance in the patients re-
ported (Edstrom et al., 1990; Lange et al., 2005), compared with
other patients who have the p.P30091L mutation (Palmio et al.,
2013; Pfeffer et al., 2014). Lange et al. (2014) hypothesize that
the kinase domain variant is the cause of the more severe pheno-
type in their patients. For the time being, there is no additional
evidence to support this hypothesis. As indirect evidence, Lange
et al. (2014) cite the importance of recessive kinase domain mu-
tations in a recent publication (Chauveau et al., 2013), although
the principal clinical finding in most of these patients was cardio-
myopathy, which does not occur in HMERF patients, and the pa-
tients have a different mode of inheritance (HMERF is autosomal
dominant).
We attempted to find evidence for a modifier effect for kinase
variants by screening a HMERF population of 33 patients, but our
findings did not support this hypothesis (Pfeffer et al., 2013). At
present we can only reach the following conclusions with any
confidence: (i) HMERF is caused by mutations in the FN119
domain of TTN (Ohlsson et al., 2012; Pfeffer et al., 2012,
2013a; Vasli et al., 2012; Hedberg et al., 2013; Izumi et al.,
2013; Palmio et al., 2013; Toro et al., 2013; Lange et al.,
2014); (ii) one particular mutation in the FN119 domain,
p.P30091L, has variable expressivity and penetrance (Palmio
et al., 2013; Pfeffer et al., 2014; Lange et al., 2014), and the
inheritance pattern may be dominant (Lange et al., 2005; Pfeffer
et al., 2014) or may be recessive (Palmio et al., 2013); (iii) in two
screening studies of patients with undiagnosed myofibrillar myop-
athy, sequencing of 172 families identified nine patients with
FN119 domain mutations, but none with kinase domain mutations
(Pfeffer et al., 2014; Toro et al., 2013); (iv) the kinase variant of
interest (R32450W/R279W) is reported in controls (it is listed in
dbSNP as rs140319117 with an allele frequency of 0.2%, and we
have also recently reported a healthy control with this variant)
(Pfeffer et al., 2013). This kinase variant does not appear to be
capable of causing HMERF; and (v) R32450W/R279W has only
been associated with HMERF in the original report by Lange et al.
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(2005). In this family, a common haplotype contains both a FN119
domain mutation and the kinase domain variant (Lange et al.,
2014). Given the more severe phenotype in these patients, it is
possible (but not proven) that the kinase domain mutation may be
a modifier of the condition caused by the mutation in the FN119
domain. Other possible explanations include a different mono-
genic factor on the same haplotype, complex genetic factors,
environmental factors, or a combination of these. Further evidence
is required to substantiate the hypothesis proposed by Lange et al.
(2014), that R32450W/R279W modifies the phenotype of
HMERF.
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